Publication of supplement to prospectus
Oncology Venture Sweden AB (”Oncology Venture”) hereby publish a supplement to the prospectus due to the press releases the company published on March 21st 2017, March 24th 2017, March 28th 2017 and March 29th 2017, after the approval of the company’s prospectus by the Swedish Financial Supervisory Authority before Oncology Venture’s rights issue with subscription period on March 16th-30th 2017. The supplement to the prospectus is available on the company’s (www.oncologyventure.com), Sedermera Fondkommission’s (www.sedermera.se) and AktieTorget’s (www.aktietorget.se) respective websites.For